Bristol-Myers Squibb: No Respect For Blowout Earnings - Buy The Richer Dividend YieldsSeeking Alpha • 08/01/25
Bristol-Myers Q2 Earnings Review: Solid Quarter, But Incoming CMO Must Fix PipelineSeeking Alpha • 08/01/25
Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challengesWSJ • 08/01/25
Bristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales ViewZacks Investment Research • 07/31/25
Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Top EstimatesZacks Investment Research • 07/31/25
Bristol Myers posts better-than-expected second quarter results on strength of top sellersReuters • 07/31/25
Will Collaboration With Bain Capital Help BMY Advance Its Pipeline?Zacks Investment Research • 07/30/25
Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of PatientsBusiness Wire • 07/28/25
Will These 5 Pharma/Biotech Bigwigs Surpass Q2 Earnings Forecasts?Zacks Investment Research • 07/28/25
4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return Potential24/7 Wall Street • 07/28/25